Andrey Leonov

Dr. Leonov received a PhD in Chemistry and Molecular Biology from Moscow State University in collaboration with Max Plank Institute for Molecular Biology (Germany).

Dr. Leonov has distinguished himself in the field of biomedical product development and research. As CEO of several biomedical research and development companies (Incuron LLC/ Incuron Inc, OncoTartis LLC, Tartis Ageing LLC), Dr. Leonov played a crucial and essential role in the companies’ successful development from small startups to the premier developers of innovative oncology and anti-ageing drugs – winners of associated grants, along with other major venture capital investments.

At CoBrain-Analytics Dr. Leonov is devoted to several projects aimed to be developed for medical applications.